Balaxi Pharmaceuticals Limited has announced a board meeting to consider the financial results for the quarter and half-year ending June 30, 2025. The company has also declared closure of its trading window for all designated persons and their immediate relatives starting July 1, 2025, until 48 hours after the results are announced. This move ensures compliance with insider trading norms and safeguards transparency for shareholders.